Stago's Headquarters Move to New Building
By LabMedica International staff writers Posted on 22 Apr 2014 |
Image: Stago\'s New Building (Photo courtesy of Stago).
Hemostasis specialist Stago (Asnières sur Seine, France) has moved its headquarters to a new building fully dedicated to its business activities. The functional, and contemporary 8,300 m² building is designed to accommodate not only the Group’s various global functions but also the activities of its French subsidiary. It will allow the company to optimize its everyday operations and to greet partners and customers in an even more welcoming environment.
Officially recognised as a low-energy, high environmental quality building, this development is part of a sustainable quality approach embodying the values that have guided Stago for nearly 70 years. This investment is an indicator of the company’s healthy balance sheet. It was made possible by its employees’ expertise and hard work, and above all by the strong support of the hemostasis scientific and medical community.
Patrick Monnot, deputy vice president Stago, commented, “The rapid acceleration in our international expansion meant we needed a new Head Office, more closely reflecting the Stago image and its operations today.”
Related Links:
Stago
Officially recognised as a low-energy, high environmental quality building, this development is part of a sustainable quality approach embodying the values that have guided Stago for nearly 70 years. This investment is an indicator of the company’s healthy balance sheet. It was made possible by its employees’ expertise and hard work, and above all by the strong support of the hemostasis scientific and medical community.
Patrick Monnot, deputy vice president Stago, commented, “The rapid acceleration in our international expansion meant we needed a new Head Office, more closely reflecting the Stago image and its operations today.”
Related Links:
Stago
Latest Industry News
- Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
- Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance